27Phosphatidylinositol-3,4,5-trisphosphate (PIP3) generation at the plasma membrane is a key event 28 during activation of receptor tyrosine kinases such as the insulin receptor and is critical for normal 29 growth and metabolism. The lipid kinases and phosphatases regulating PIP3 levels are described but 30 mechanisms that control their activity remains unclear. We report that in Drosophila, 31phosphatidylinositol 5 phosphate 4-kinase (PIP4K) regulates PIP3 levels during insulin receptor 32 activation. Depletion of PIP4K increases PIP3 levels and augments sensitivity to insulin through 33 enhanced Class I phosphoinositide 3-kinase (PI3K) activity. Plasma membrane localized PIP4K was 34 sufficient to control PIP3 levels. Animals lacking PIP4K show enhanced insulin dependent phenotypes 35 in vivo and show resistance to the metabolic consequences of a high-sugar diet. Thus, PIP4K is required 36 for normal metabolism and development. Our work defines PIP4Ks as regulators of receptor tyrosine 37 kinase signalling with implications for growth factor dependent processes including tumour growth, T-38 cell activation and metabolism.Lipid kinases that can phosphorylate selected positions on the inositol head group of 58 phosphatidylinositol (PI), generate second messengers that regulate multiple processes in eukaryotic 59 cells. The generation of phosphatidylinositol 3,4,5-trisphosphate (PIP3) through the action of Class I 60 PI3K following growth factor receptor (e.g Insulin receptor) stimulation, is a widespread signalling 61 reaction (Hawkins et al., 2006) that regulates normal growth and development (Engelman et al., 2006). 62The role of Class I PI3K activation in response to insulin receptor signalling is evolutionarily conserved 63 and has been widely studied in metazoan models such as the fly, worm and mammals (Barbieri et al., 64 2003). Robust control of the levels and the dynamics of PIP3 turnover is essential to maintain fidelity and 65 sensitivity of information transfer during insulin signalling. This is achieved through a number of 66 different molecular mechanisms. The Class I PI3K enzyme is a dimer of a catalytic subunit (p110) whose 67 activity is inhibited under unstimulated conditions by the regulatory subunit (p85/50/55/60). Upstream 68 receptor activation and subsequent binding to p-Tyr residues on the receptor and adaptor proteins 69 relieves this inhibition. In addition, lipid phosphatases are also important in controlling PIP3 levels at 70 the plasma membrane. PTEN, a 3-phosphatase, hydrolyzes PIP3 to produce PI(4,5)P2 (McConnachie et 71 al., 2003) while SHIP2 is a 5-phosphate that generates PI(3,4)P2 from PIP3 (Pesesse et al., 1998). It is well 72 documented that mutations in genes encoding any of these enzymes can be oncogenic or result in 73 metabolic syndromes. Loss of function in PTEN or gain of function in Class I PI3K genes results in 74 tumour development (Luo et al., 2003) while loss of SHIP2 results in altered insulin sensitivity in 75 mammals (Clément et al., 2001; Kaisaki et al., ...